Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy : Clinical Implications for Multimodal Therapy

MLA

David Pfister, et al. Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-Specific Antigen After Salvage Lymph Node Dissection for Node-Only Recurrent Prostate Cancer After Radical Prostatectomy : Clinical Implications for Multimodal Therapy. Oct. 2022. EBSCOhost, https://doi.org/10.22028/d291-37690.

APA

David Pfister, Francesco Barletta, Alessandro Nini, R. Jeffrey Karnes, Alexandre Mottrie, Andreas Hiester, Inderbir S. Gill, Shahrokh F. Shariat, Riccardo Schiavina, Matteo Droghetti, Nazareno Suardi, Axel Heidenreich, Alberto Briganti, Peter Albers, Carlo Andrea Bravi, Christian G. Stief, Nicola Fossati, Alexander Kretschmer, Bernhard Grubmüller, … Simone Scuderi. (2022). Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy : Clinical Implications for Multimodal Therapy. https://doi.org/10.22028/d291-37690

Chicago

David Pfister, Francesco Barletta, Alessandro Nini, R. Jeffrey Karnes, Alexandre Mottrie, Andreas Hiester, Inderbir S. Gill, et al. 2022. “Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-Specific Antigen After Salvage Lymph Node Dissection for Node-Only Recurrent Prostate Cancer After Radical Prostatectomy : Clinical Implications for Multimodal Therapy,” October. doi:10.22028/d291-37690.